New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape is a new seven-country report designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides market share estimates, specimen, test and sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers. Research Beam Model: Research Beam Product ID: 174936 21100 USD New
2014-2018 World Hematology and Flow Cytometry Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-France, Germany, Italy, Japan, Spain, UK, US

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2014-2018 World Hematology and Flow Cytometry Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers-France, Germany, Italy, Japan, Spain, UK, US

 
  • Category : Diagnostic and Biotech
  • Published On : November  2014
  • Pages : 700
 
 

New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape is a new seven-country report designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. 



The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides market share estimates, specimen, test and sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.



Rationale 



During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.



Geographic Coverage 



France, Germany, Italy, Japan, Spain, UK, USA 



Worldwide Market Overview



- Facilities performing hematology and flow cytometry



testing by country.



- Test volume and sales projections by country.



Strategic Recommendations



- New product development opportunities



with significant market appeal.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



Market Segmentation Analysis



- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.



- Specimen, test and sales forecasts for over 40 procedures



by country, individual test and market segment:



- Hospitals



- Commercial/Private Laboratories



- Ambulatory Care Centers



- Physician Offices/Group Practices



Sales and Market Share Analysis



- Sales and market shares of major 



instrument and reagent suppliers.



Hematology Tests



CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), 



Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), 



Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.



Flow Cytometry Tests



Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.



Current and Emerging Products



- Analysis of current and emerging hematology and flow cytometry assays.



- Reagent and instrument sales forecasts by market segment.



- Instrument placements and installed base by manufacturer and model.



- Sales and market shares of reagent and instrument suppliers.



Instrumentation Review



- The study reviews current instrumentation technologies, and compares features



of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.



- The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.



Technology Review



- Assessment of current and emerging technologies 



and their potential market applications.



- Comprehensive lists of companies developing



or marketing new technologies and products by test.



Competitive Assessments



- Extensive strategic profiles of major suppliers and emerging market entrants.



- The companies analyzed in the report include: 



- Abbott



- Agilent Technologies



- Beckman Coulter/Danaher



- Becton Dickinson



- Bio-Rad



- CellaVision



- Horiba



- Iris/Danaher



- Nihon Kohden



- Ortho-Clinical Diagnostics



- Roche



- Siemens



- Sysmex



Contains 700 pages and 250 tables